Physician profile
William J Ryan
NPI 1063916500
$1,867.73
in general payments reported to CMS, 2019-2025
9 companies · $355 in 2025
The $355 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $132 · 2023: $343 · 2024: $1,038 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,735.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,028.13 | 2022-2025 | Eluvia, General - Vascular Intervention, Ranger |
| Stryker Corporation | $247.67 | 2024-2025 | Gamma, Clottriever Bold Catheter, Artix Mt |
| Haemonetics Corporation | $165.76 | 2023 | Teg5000 Hemostasis Analyzer |
| Smith+Nephew, INC. | $154.10 | 2024 | Stravix, Grafix, Oasis |
| Balt USA, LLC | $152.26 | 2024 | Prestige Coil System |
| C. R. Bard, INC. & Subsidiaries | $65.56 | 2025 | Covera |
| Surmodics, INC. | $20.61 | 2024 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Penumbra, INC. | $17.93 | 2024 | Indigo System |
| Seagen INC. | $15.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.